Abstract
For all their high profile, US biotechnology companies in genetics do not yet seem to offer a stable career, because of uncertainties about corporate performance. Meanwhile, attempts are being made to assess the future shape of genetic counselling services, and to attract non-biologists to genome research.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
